Catalyst
Slingshot members are tracking this event:
Eisai (ESALY) and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR (lorcaserin HCl) Extended-Release Tablets
- Source Link:
- http://www.eisai.com/news/enews201652pdf.pdf
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARNA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 19, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Belviq Xr, Lorcaserin Hci, Venespri, Lorcaserin Hydrochloride
